These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9761374)

  • 1. Natural killer cell mediated cytotoxicity against VERO target cells; the suppressive effect of pentoxifylline.
    Nagy Z; Mándi Y
    Immunol Lett; 1998 Sep; 63(2):121-3. PubMed ID: 9761374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive effects of pentoxifylline on natural killer cell activity.
    Reed WR; DeGowin RL
    J Lab Clin Med; 1992 Jun; 119(6):763-71. PubMed ID: 1593221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response modulation by pentoxifylline in vitro.
    Tilg H; Eibl B; Pichl M; Gächter A; Herold M; Brankova J; Huber C; Niederwieser D
    Transplantation; 1993 Jul; 56(1):196-201. PubMed ID: 8333042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid solubility- and concentration-dependent attenuation of in vitro natural killer cell cytotoxicity by local anesthetics.
    Krog J; Hokland M; Ahlburg P; Parner E; Tønnesen E
    Acta Anaesthesiol Scand; 2002 Aug; 46(7):875-81. PubMed ID: 12139545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
    Steele TA; Brahmi Z
    J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of maximal exercise on natural killer (NK) cell cytotoxicity and responsiveness to interferon-alpha in the young and old.
    Woods JA; Evans JK; Wolters BW; Ceddia MA; McAuley E
    J Gerontol A Biol Sci Med Sci; 1998 Nov; 53(6):B430-7. PubMed ID: 9823739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon.
    Fuggetta MP; Graziani G; Aquino A; D'Atri S; Bonmassar E
    Int J Immunopharmacol; 1988; 10(6):687-94. PubMed ID: 3198305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of rat natural killer (NK) cell cytotoxicity and cytokine production by 3-methylcholanthrene (3-MC).
    Talcott PA; Exon JH; Mather GG; Koller LD
    Int J Immunopharmacol; 1990; 12(8):917-26. PubMed ID: 2292469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
    Uchida A; Klein E
    Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of 2.35-T MR imaging on natural killer cell cytotoxicity with and without interleukin-2.
    Prasad N; Lotzová E; Thornby JI; Taber KH
    Radiology; 1990 Apr; 175(1):261-3. PubMed ID: 2315491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive effect of pentoxifylline on natural killer cell activity; experimental and clinical studies.
    Nagy Z; Sipka R; Ocsovszki I; Balogh A; Mándi Y
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):228-34. PubMed ID: 10208310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased natural killer (NK) susceptibility of human NK target cells after phosphatidylinositol-specific phospholipase C treatment.
    Uggla C; Une C; Axberg I; Jondal M; Knowles RW; Orn A
    Scand J Immunol; 1989 Jan; 29(1):83-9. PubMed ID: 2537997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy with cytokine-transfected xenogenic cells (Vero-IL-2) in patients with metastatic solid tumors: mechanism(s) of elimination of the transgene-carrying cells.
    Jantscheff P; Herrmann R; Spagnoli G; Reuter J; Mehtali M; Courtney M; Rochlitz C
    Cancer Immunol Immunother; 1999 Sep; 48(6):321-30. PubMed ID: 10473807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human lymphocyte natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity by K-76 COONa, a reagent that blocks complement activity.
    Hudig D; Redelman D; Minning L; Carine K
    J Immunol; 1984 Jul; 133(1):408-14. PubMed ID: 6725955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocorticotropin stimulates natural killer cell activity.
    McGlone JJ; Lumpkin EA; Norman RL
    Endocrinology; 1991 Sep; 129(3):1653-8. PubMed ID: 1651855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell and lymphokine-activated killer cell activity against melanocytes in vitiligo.
    Durham-Pierre DG; Walters CS; Halder RM; Pham HN; Vanderpool EA
    J Am Acad Dermatol; 1995 Jul; 33(1):26-30. PubMed ID: 7601942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of leukotriene C4 synthesis and natural killer activity by ethacrynic acid.
    Leung KH
    Cell Immunol; 1988 Jul; 114(2):359-69. PubMed ID: 3390866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of canine distemper virus on natural killer cell activity in dogs.
    Ringler SS; Krakowka S
    Am J Vet Res; 1985 Aug; 46(8):1781-6. PubMed ID: 4037509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.